Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Petros

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Pharmacotherapy|January 1, 1992
Pharmacokinetics and administration of colony-stimulating factorsW P Petros
Current Opinion in Hematology|May 1, 1997
Safety of concomitant use of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor with cytotoxic chemotherapy agentsW P Petros, J Crawford
Hospital Pharmacy|June 9, 1986
A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implicationsW P Petros, W A Shank
Pharmacotherapy|January 1, 1990
Pharmacokinetics and pharmacodynamics of anticancer agents: contributions to the therapy of childhood cancerW P Petros, W E Evans
Bone Marrow Transplantation|January 1, 1993
Cost implications of haematopoietic growth factors in the BMT settingW P Petros, W P Peters
Pharmacotherapy|April 22, 1999
Two instruments to determine activated partial thromboplastin time: implications for heparin monitoringC T Taylor, W P Petros, T L Ortel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Clinical pharmacology of filgrastim following high-dose chemotherapy and autologous bone marrow transplantationW P Petros, J Rabinowitz, A Stuart, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1991
Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemiaW P Petros, J H Rodman, J Mirro, et al.
Blood|May 1, 1993
Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow supportJ Rabinowitz, W P Petros, A R Stuart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trialL M Sutton, M A Warmuth, W P Petros, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Pharmacotherapy|January 1, 1992
Pharmacokinetics and administration of colony-stimulating factorsW P Petros
Current Opinion in Hematology|May 1, 1997
Safety of concomitant use of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor with cytotoxic chemotherapy agentsW P Petros, J Crawford
Hospital Pharmacy|June 9, 1986
A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implicationsW P Petros, W A Shank
Pharmacotherapy|January 1, 1990
Pharmacokinetics and pharmacodynamics of anticancer agents: contributions to the therapy of childhood cancerW P Petros, W E Evans
Bone Marrow Transplantation|January 1, 1993
Cost implications of haematopoietic growth factors in the BMT settingW P Petros, W P Peters
Pharmacotherapy|April 22, 1999
Two instruments to determine activated partial thromboplastin time: implications for heparin monitoringC T Taylor, W P Petros, T L Ortel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Clinical pharmacology of filgrastim following high-dose chemotherapy and autologous bone marrow transplantationW P Petros, J Rabinowitz, A Stuart, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1991
Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemiaW P Petros, J H Rodman, J Mirro, et al.
Blood|May 1, 1993
Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow supportJ Rabinowitz, W P Petros, A R Stuart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trialL M Sutton, M A Warmuth, W P Petros, et al.
Pageof 5